MBX Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 16 Sep 24 | BuyUS$8,000,000 | New Enterprise Associates, Inc. | Company | 500,000 | US$16.00 | |
| 16 Sep 24 | BuyUS$12,000,000 | OrbiMed Advisors LLC | Company | 750,000 | US$16.00 | |
| 16 Sep 24 | BuyUS$12,000,000 | NVP Associates, LLC | Company | 750,000 | US$16.00 | |
| 16 Sep 24 | BuyUS$10,000,000 | Frazier Life Sciences Management, LP | Company | 625,000 | US$16.00 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 998,392 | 2.99% |
| Institutions | 1,790,122 | 5.36% |
| General Public | 12,027,866 | 36% |
| VC/PE Firms | 18,567,318 | 55.6% |
Dilution of Shares: MBX only recently listed within the past 12 months
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 5,985,347 | US$143.3m | 0% | 6.13% | |||
| 3,812,215 | US$91.3m | 0% | 1.3% | |||
| 3,614,486 | US$86.6m | 0% | 4.27% | |||
| 3,018,935 | US$72.3m | 0% | 1.98% | |||
| 2,136,335 | US$51.2m | 0% | 13.88% | |||
| 1,790,122 | US$42.9m | 0% | 0.01% | |||
| 879,674 | US$21.1m | 0% | no data | |||
| 102,082 | US$2.4m | 0% | no data | |||
| 16,636 | US$398.4k | 0% | no data |